Skip to main content
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2002 Jun;78(3):204–207. doi: 10.1136/sti.78.3.204

Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua

P Claeys, C Gonzalez, M Gonzalez, L Van Renterghem, M Temmerman
PMCID: PMC1744476  PMID: 12238655

Abstract

Methods: Consecutive women attending women's health clinics in different regions were interviewed and examined for STI, HIV, and cervical neoplasia.

Results: Whereas only 30.4% of the 1185 participating women attended the clinics because of STI related complaints, 77.0% reported symptoms after probing. Clinical cervicitis was diagnosed in 32.8%, Chlamydia trachomatis in 4.1%, gonorrhoea in 0.4%, trichomoniasis in 10.2%. Antibodies for syphilis were found in 0.7%, for hepatitis B in 3.7%, and none were HIV seropositive. The STI prevalence was 21.8% in women attending with complaints, 17.3% in symptomatic women after probing, and 14.8% in asymptomatic women. Abnormal Papanicolaou (Pap) smears were found in 7.7%, with high risk human papilloma virus (HPV) types in almost 60%. Male promiscuity was associated with high grade squamous intraepithelial lesions (HSIL) and reported former screening was not shown to be protective. Young age and being employed were risk factors for C trachomatis.

Conclusion: Nearly one out of five women attending women's health clinics in Nicaragua had an STI, and one out of 13 a precancerous lesion of the cervix. These clinics provide an opportunity to improve the reproductive health of women by probing for STI symptoms, especially in young women, and by offering cervical screening to casual attendees. Of concern is the high rate of cervical lesions in women with a screening history, underlining the need for proper quality control.

Full Text

The Full Text of this article is available as a PDF (143.3 KB).


Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES